We're on it: CB Insights’ 2024 List of the 50 Most Innovative Digital Health

December 3, 2024

Mindpeak has been chosen as one of the 50 most promising digital health companies in the world by CB Insights.

The ranking, “Digital Health 50,” annually highlights the most impactful private digital healthcare companies developing innovative tools tailored for use by clinicians, healthcare institutions, and life sciences entities.

Mindpeak achieved recognition as a leading AI-driven pathology and diagnostics innovator, advancing cancer care with its cutting-edge AI-powered solutions.


Read more: https://lnkd.in/eJxpSJib

In the News

Related reading

In the News
8 min read

Mindpeak Expands to the United States with New Headquarters in Boston

We are proud to announce the official launch of Mindpeak Inc. in Boston, establishing our new US headquarters at the heart of the world’s leading pharma, biotech, and diagnostics ecosystem.

This milestone represents more than the opening of an office. It reflects our commitment to collaborating closely with innovators across the United States to:

  • Accelerate biomarker discovery and companion diagnostics
  • Advance the development of cancer therapies
  • Enable faster, more precise matching of treatments to patients

With a permanent presence in the US, we are making advanced AI-powered pathology part of everyday workflows—providing reproducible, high-quality insights that transform complex data into better patient outcomes.

At Mindpeak, we look forward to building strong partnerships and shaping the future of precision medicine together.

Read the full article here

In the News
8 min read

Mindpeak Featured in Ada Ventures’ Bio‑Infrastructure Spotlight

We’re excited to share that Mindpeak has been recognized by Ada Ventures as part of a select group of innovators building the next-generation infrastructure for global health.

In their recent spotlight, Ada Ventures highlights the urgency of rethinking healthcare systems to meet the demands of a longer-living, more complex global population. Their vision spans five critical pillars of bio‑infrastructure—from lab automation to talent development, with Mindpeak featured under "Patient Data Platforms" for our contributions to secure, inclusive, and actionable health data.

At Mindpeak, we’re proud to play a pivotal role in this transformation:

Advancing Precision Diagnostics

Our AI software brings cutting-edge biomarker translation directly into pathology workflows—supporting clinicians in identifying breast, lung, and other cancers with speed and precision.

Making Patient Data Clinically Useful

Unlike conventional data platforms, we focus on real-time, tissue-based insights that are immediately actionable in the clinic. This enables faster decision-making and more equitable access to personalized care.

Scaling Globally

With deployments across 20+ countries and partnerships with leading labs, we’re not just imagining the future, we’re delivering it, one slide at a time.

We’re honored to be included alongside visionary companies across the healthcare and life sciences ecosystem. Together, we’re helping build a world where AI, data, and infrastructure truly serve everyone.

🔗 Read Ada Ventures’ full bio‑infrastructure spotlight

In the News
8 min read

Mindpeak GmbH featured at AlbionVC HLTH 2025

We’re thrilled that Mindpeak GmbH has been featured in the AlbionVC HLTH Europe HealthTech Market Map 2025, which includes leading companies across digital care and digital pharma in Europe!

Explore the European HealthTech landscape in AlbionVC’s interactive map: https://lnkd.in/da6H84sJ

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting